募资6.25亿美元创五年之最减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克

智通财经04-17

智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.(KLRA.US)通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。这家总部位于马萨诸塞州沃尔瑟姆的公司将其IPO定价定在此前公布价格区间的上限。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2628221198?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-17 11:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628221198","market":"hk","top_or_hot":-1,"title":"募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.(KLRA.US)通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。这家总部位于马萨诸塞州沃尔瑟姆的公司将其IPO定价定在此前公布价格区间的上限。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1429802.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-17 11:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1429802.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.(KLRA.US)通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。这家总部位于马萨诸塞州沃尔瑟姆的公司将其IPO定价定在此前公布价格区间的上限。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1429802.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QID","symbol_name":"两倍做空纳斯达克指数ETF-ProShares","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1429802.html","article_id":"2628221198","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628221198","pubTimestamp":1776396818,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.通过扩大首次公开发行规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股股票。包括贝恩资本旗下Bain Capital Private Equity、Bain Capital Life Sciences和卡塔尔投资局在内的现有股东已表示，有意按IPO价格合计购买最多2.25亿美元的公司股票。此次IPO之前，Kailera已于去年10月通过B轮融资募资6亿美元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"QID":"两倍做空纳斯达克指数ETF-ProShares","QQQE":"Direxion NASDAQ-100 Equal Weighted Index Shares","BK4007":"制药","SQQQ":"纳指三倍做空ETF","BK4539":"次新股","NVIW.SI":"NVDA 3xLongSG261006","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","PSQ":"做空纳斯达克100指数ETF-ProShares","ONEQ":"Fidelity NASDAQ Composite Index ETF","QYLG":"Nasdaq 100 Covered Call & Growth ETF","IYW":"美国科技ETF-iShares","QDTE":"Roundhill N-100 0DTE Covered Call Strategy ETF","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","BK1147":"投资银行业与经纪业","BK4139":"生物科技","KLRA":"Kailera Therapeutics, Inc.","FTEC":"Fidelity MSCI Information Techno","QQQM":"NASDAQ100指数ETF-Invesco","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","QQQ":"纳指100ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","TQQY":"GraniteShares YieldBOOST QQQ ETF"},"translate_title":"Kailera Therapeutics (KLRA.US), a weight-loss drug upstart in five years with $625 million raised, landed on Nasdaq tonight","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/703bdfa138471cb9c61e287cb3a8f0ac","symbols_score_info":{"MNQmain":0.6,"NVIW.SI":0.6,"QQQA":0.6,"IYW":0.6,"QDTE":0.6,"TQQY":0.6,"QQQY":0.6,"QQQE":0.6,"ONEQ":0.6,"JEPQ":0.6,"PSQ":0.6,"QQQ":0.6,"QLD":0.6,"QQQM":0.6,"GPIQ":0.6,"QYLG":0.6,"QQQJ":0.6,"KLRA":1.98,"TQQQ":0.6,"FTEC":0.6,"SQQQ":0.6,"QID":0.6},"content_text":"智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.(KLRA.US)通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。这家总部位于马萨诸塞州沃尔瑟姆的公司将其IPO定价定在此前公布价格区间的上限。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股股票。该公司此前计划以每股14至16美元的价格发行3330万股。据知情人士透露，本次IPO获超额认购，超额倍数达两位数。按发行价计算，基于招股文件中列出的流通股数量，Kailera的市值约为20亿美元。汇编数据显示，此次上市是2021年以来美国生物科技领域规模最大的IPO——上一纪录由细胞工程公司Sana Biotechnology Inc.(SANA.US)创下，该公司当年IPO募资6.76亿美元。Kailera将进入一个竞争日益激烈的药物研发赛道，各家药企纷纷争抢到2030年可能达到2000亿美元的肥胖症治疗市场份额。其中，礼来(LLY.US)和诺和诺德(NVO.US)凭借已获美国FDA批准的减肥药(包括口服和注射剂)处于领先地位。Kailera成立于2024年，是一家处于临床后期的生物科技公司，正在开发四种基于GLP-1的减肥药物，其中包括一款每周注射一次的药物和一款每日口服一次的药片，目前均已进入后期临床试验阶段。包括贝恩资本旗下Bain Capital Private Equity、Bain Capital Life Sciences和卡塔尔投资局在内的现有股东已表示，有意按IPO价格合计购买最多2.25亿美元的公司股票。根据招股文件，贝恩资本的相关附属公司在发行后将持有公司约三分之一的股份。财务数据方面，Kailera在截至2025年12月的年度内净亏损1.49亿美元，而其在2024年5月成立至2024年12月期间的净亏损为2.197亿美元。Kailera由Ronald Renaud领导，他曾担任Cerevel Therapeutics的首席执行官，直至该公司于2024年被艾伯维(ABBV.US)以87亿美元收购。此次IPO之前，Kailera已于去年10月通过B轮融资募资6亿美元。该轮融资由Bain Capital Private Equity领投，新投资者包括Janus Henderson Investors、Surveyor Capital和Invus，现有投资者包括Atlas Venture、Bain Capital Life Sciences和Sirona Capital也参与了投资。本次发行的牵头承销商包括摩根大通、杰富瑞、Leerink Partners LLC、Cowen Inc. 和Evercore Inc.。该公司股票预计于周五在纳斯达克全球市场开始交易，代码为“KLRA”。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628221198","isCrawlerRequest":true}

募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克

精彩评论

募资6.25亿美元创五年之最减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克